Sarepta Therapeutics, Inc.

NASDAQ:SRPT

123.29 (USD) • At close November 1, 2024
Bedrijfsnaam Sarepta Therapeutics, Inc.
Symbool SRPT
Munteenheid USD
Prijs 123.29
Beurswaarde 11,757,711,127
Dividendpercentage 0%
52-weken bereik 75.85 - 173.25
Industrie Biotechnology
Sector Healthcare
CEO Mr. Douglas S. Ingram Esq.
Website https://www.sarepta.com

An error occurred while fetching data.

Over Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that

Vergelijkbare Aandelen

Nutex Health, Inc. logo

Nutex Health, Inc.

NUTX

22.6 USD

R1 RCM Inc. logo

R1 RCM Inc.

RCM

14.26 USD

ShockWave Medical, Inc. logo

ShockWave Medical, Inc.

SWAV

334.75 USD

Sotera Health Company logo

Sotera Health Company

SHC

15.86 USD

Exelixis, Inc. logo

Exelixis, Inc.

EXEL

34.12 USD

Halozyme Therapeutics, Inc. logo

Halozyme Therapeutics, Inc.

HALO

57.15 USD

10x Genomics, Inc. logo

10x Genomics, Inc.

TXG

16.33 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)